Algerian lung cancer registry study
Part of Cancer, Lungs & breathing clinical trials.
This study tracks people diagnosed with lung cancer to learn more about the disease and its treatment in Algeria. By joining, you help build a better understanding of lung cancer care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with lung cancer (non-small cell, small cell, or carcinoid) within the past year, or are being diagnosed now.
- You will get your cancer care at one of the 21 participating public or university hospitals in Algeria.
- You are willing and able to sign a consent form.
- You have not already joined this study, and you are not taking part in another clinical trial that tests a new treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This observational study follows adults with newly diagnosed non-small cell lung cancer to understand what treatments are used and how patients are doing. It may help doctors better understand how care decisions affect outcomes, and it does not require the study to give an experimental treatment.
This trial collects blood and tissue samples from people newly diagnosed with lung cancer (NSCLC or CPC) to study the disease over time. It helps researchers understand how different treatments affect the cancer and the body.
This study looks at how stomach cancer is diagnosed and treated in Algeria. It helps doctors learn more about the disease to improve care for future patients.
This study looks at how prostate cancer is found and treated in Algeria. The goal is to learn more about the disease to improve care for future patients.
This study builds a detailed lung-cancer database by collecting clinical and lab information from people newly diagnosed. It aims to help doctors better understand lung cancer and how patients are treated from the start.
This study looks at treatments and care for people living in Tunisia who have been diagnosed with lung cancer. It may help researchers learn more about options available for lung cancer patients.
Hear when a new Lung Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.